Literature DB >> 10086384

Fas ligand (CD95 ligand) controls angiogenesis beneath the retina.

H J Kaplan1, M A Leibole, T Tezel, T A Ferguson.   

Abstract

A principal cause of blindness is subretinal neovascularization associated with age-related macular degeneration. Excised neovascular membranes from patients with age-related macular degeneration demonstrated a pattern of Fas+ new vessels in the center of the vascular complex, surrounded by FasL+ retinal pigment epithelial cells. In a murine model, Fas (CD95)-deficient (Ipr) and FasL-defective (gld) mice had a significantly increased incidence of neovascularization compared with normal mice. Furthermore, in gld mice there is massive subretinal neovascularization with uncontrolled growth of vessels. We found that cultured choroidal endothelial cells were induced to undergo apoptosis by retinal pigment epithelial cells through a Fas-FasL interaction. In addition, antibody against Fas prevented vascular tube formation of choroidal endothelial cells derived from the eye in a three-dimensional in vitro assay. Thus, FasL expressed on retinal pigment epithelial cells may control the growth and development of new subretinal vessels that can damage vision.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10086384     DOI: 10.1038/6509

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  36 in total

1.  Transcription-controlled gene therapy against tumor angiogenesis.

Authors:  Shoshana Greenberger; Aviv Shaish; Nira Varda-Bloom; Keren Levanon; Eyal Breitbart; Iris Goldberg; Iris Barshack; Israel Hodish; Niva Yaacov; Livnat Bangio; Tanya Goncharov; David Wallach; Dror Harats
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

Review 2.  Age-related macular degeneration: genetic and environmental factors of disease.

Authors:  Yuhong Chen; Matthew Bedell; Kang Zhang
Journal:  Mol Interv       Date:  2010-10

Review 3.  Endothelial cell apoptosis in angiogenesis and vessel regression.

Authors:  Emma C Watson; Zoe L Grant; Leigh Coultas
Journal:  Cell Mol Life Sci       Date:  2017-06-23       Impact factor: 9.261

4.  VEGF-A regulates the expression of VEGF-C in human retinal pigment epithelial cells.

Authors:  B Zhao; A Ma; J Cai; M Boulton
Journal:  Br J Ophthalmol       Date:  2006-05-10       Impact factor: 4.638

5.  The bst locus on mouse chromosome 16 is associated with age-related subretinal neovascularization.

Authors:  R S Smith; S W John; A Zabeleta; M T Davisson; N L Hawes; B Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 6.  Role of growth factors and the wound healing response in age-related macular degeneration.

Authors:  Reinier O Schlingemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

7.  miR-30a-5p inhibition promotes interaction of Fas+ endothelial cells and FasL+ microglia to decrease pathological neovascularization and promote physiological angiogenesis.

Authors:  Salome Murinello; Yoshihiko Usui; Susumu Sakimoto; Maki Kitano; Edith Aguilar; H Maura Friedlander; Amelia Schricker; Carli Wittgrove; Yoshihiro Wakabayashi; Michael I Dorrell; Peter D Westenskow; Martin Friedlander
Journal:  Glia       Date:  2018-11-28       Impact factor: 7.452

8.  Essential role for hematopoietic Fas ligand (FasL) in the suppression of melanoma lung metastasis revealed in bone marrow chimeric mice.

Authors:  Christopher L Hall; Mike Yao; Laurie L Hill; Laurie B Owen-Schaub
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

Review 9.  Angiogenesis in eye disease: immunity gained or immunity lost?

Authors:  Thomas A Ferguson; Rajendra S Apte
Journal:  Semin Immunopathol       Date:  2008-02-23       Impact factor: 9.623

10.  JNK inhibition reduces apoptosis and neovascularization in a murine model of age-related macular degeneration.

Authors:  Hongjun Du; Xufang Sun; Monica Guma; Jing Luo; Hong Ouyang; Xiaohui Zhang; Jing Zeng; John Quach; Duy H Nguyen; Peter X Shaw; Michael Karin; Kang Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.